Osamu Ohara Selected Research

human protein 4.1B

12/2004

Immunolocalization of protein 4.1B/DAL-1 during neoplastic transformation of mouse and human intestinal epithelium.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Osamu Ohara Research Topics

Disease

26	Neoplasms (Cancer) 11/2021 - 10/2003
13	Inflammation (Inflammations) 12/2021 - 10/2009
10	Infections 01/2021 - 12/2010
7	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2022 - 08/2011
6	Virus Diseases (Viral Diseases) 01/2021 - 12/2011
6	Leukemia 02/2016 - 05/2009
5	Primary Immunodeficiency Diseases 01/2019 - 01/2009
4	Inborn Genetic Diseases (Disease, Hereditary) 01/2022 - 06/2010
4	Asthma (Bronchial Asthma) 10/2020 - 05/2014
3	Chronic Granulomatous Disease 01/2021 - 05/2013
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 04/2013
3	Job Syndrome (Hyper-IgE Syndrome) 01/2021 - 12/2014
3	Dermatitis 01/2021 - 01/2016
3	Chronic Mucocutaneous Candidiasis 12/2020 - 08/2012
3	Rhinosinusitis 10/2020 - 01/2019
3	Fever (Fevers) 01/2020 - 07/2014
3	Cryopyrin-Associated Periodic Syndromes 01/2019 - 04/2012
3	Obesity 11/2018 - 07/2011
3	Adenocarcinoma 01/2018 - 12/2004
3	Carcinoma (Carcinomatosis) 01/2017 - 10/2003
3	Lung Neoplasms (Lung Cancer) 01/2017 - 11/2010
3	Wiskott-Aldrich Syndrome 11/2015 - 02/2013
3	Rheumatoid Arthritis 10/2015 - 05/2014
3	Contact Dermatitis (Eczema, Contact) 05/2015 - 04/2003
2	Pneumonia (Pneumonitis) 10/2022 - 05/2014
2	2 X-Linked Lymphoproliferative Syndrome 01/2022 - 10/2021
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 10/2021
2	Pemphigus (Pemphigus Vulgaris) 01/2022 - 01/2020
2	Thrombocytopenia (Thrombopenia) 08/2021 - 02/2013
2	Rare Diseases (Rare Disease) 07/2021 - 01/2008
2	IRAK4 Deficiency 01/2021 - 01/2016
2	Familial Mediterranean Fever (Periodic Disease) 01/2021 - 04/2010
2	Liver Cirrhosis (Hepatic Cirrhosis) 11/2020 - 12/2017
2	Fatty Liver 11/2020 - 07/2013
2	Colorectal Neoplasms (Colorectal Cancer) 06/2020 - 01/2018
2	Nasal Polyps (Nasal Polyp) 01/2020 - 01/2019
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019 - 01/2018
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2019 - 01/2018
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2019 - 04/2006
2	Fibrosis (Cirrhosis) 11/2018 - 01/2017
2	Hyper-IgM Immunodeficiency Syndrome (Hyper-IgM Syndrome) 10/2018 - 01/2018
2	Common Variable Immunodeficiency 01/2018 - 05/2013
2	Mycoses (Diseases, Fungus) 07/2017 - 12/2012
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2017 - 03/2016
2	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 10/2015 - 12/2010
2	Bruton type agammaglobulinemia 03/2015 - 02/2015

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2003
8	DNA (Deoxyribonucleic Acid)IBA 07/2021 - 04/2012
8	CytokinesIBA 01/2020 - 10/2009
7	RNA (Ribonucleic Acid)IBA 01/2022 - 08/2016
6	AntigensIBA 01/2020 - 01/2016
5	ChemokinesIBA 01/2018 - 04/2003
4	Interleukin-6 (Interleukin 6)IBA 01/2022 - 05/2014
4	ProteomeIBA 01/2022 - 11/2020
4	Immunoglobulin G (IgG)IBA 01/2022 - 01/2018
4	Messenger RNA (mRNA)IBA 11/2021 - 01/2004
4	InterferonsIBA 01/2020 - 11/2010
4	Immunoglobulins (Immunoglobulin)IBA 11/2018 - 05/2013
4	LigandsIBA 01/2018 - 12/2011
3	AutoantibodiesIBA 10/2022 - 04/2013
3	Immunoglobulin M (IgM)IBA 01/2022 - 04/2013
3	Interleukin-4 (Interleukin 4)IBA 01/2022 - 05/2014
3	SteroidsIBA 01/2022 - 01/2004
3	Interleukin-5 (Interleukin 5)IBA 12/2021 - 01/2013
3	STAT1 Transcription FactorIBA 12/2020 - 07/2017
3	Biomarkers (Surrogate Marker)IBA 11/2020 - 06/2014
3	Fatty Acids (Saturated Fatty Acids)IBA 11/2020 - 01/2019
2	X-Linked Inhibitor of Apoptosis ProteinIBA 01/2022 - 10/2021
2	LipopolysaccharidesIBA 01/2022 - 12/2021
2	Desmoglein 3IBA 01/2022 - 01/2020
2	EnzymesIBA 12/2021 - 01/2019
2	Complement System Proteins (Complement)IBA 07/2021 - 10/2013
2	Antiviral Agents (Antivirals)IBA 01/2021 - 04/2006
2	AntibodiesIBA 01/2021 - 12/2012
2	PyrinIBA 01/2021 - 04/2010
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021 - 07/2012
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2021 - 01/2021
2	Interleukin-17 (Interleukin 17)IBA 01/2021 - 05/2014
2	VaccinesIBA 01/2021 - 03/2016
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2020 - 01/2020
2	Peptides (Polypeptides)IBA 06/2020 - 02/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 05/2014
2	A-Form DNA (A-DNA)IBA 01/2020 - 12/2017
2	CollagenIBA 01/2019 - 01/2017
2	InflammasomesIBA 01/2019 - 01/2015
2	CD40 Ligand (CD40L)IBA 10/2018 - 01/2018
2	Pharmaceutical PreparationsIBA 06/2017 - 01/2004
2	Complementary DNA (cDNA)IBA 02/2017 - 04/2003
2	Protein Isoforms (Isoforms)IBA 01/2017 - 12/2004
2	PerforinIBA 01/2017 - 12/2013
2	ZincIBA 10/2016 - 08/2014
2	Peptide Hydrolases (Proteases)FDA Link 01/2016 - 05/2014
2	tocilizumab (atlizumab)FDA Link 10/2015 - 06/2014
2	Agammaglobulinaemia Tyrosine KinaseIBA 03/2015 - 02/2015

Therapy/Procedure

13	Therapeutics 01/2021 - 11/2010
5	Immunotherapy 01/2017 - 01/2016
4	Hematopoietic Stem Cell Transplantation 01/2019 - 05/2009
3	Transplantation 11/2021 - 10/2005
2	Stem Cell Transplantation 03/2019 - 03/2016
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 11/2015 - 12/2010